GOYAL ARJUN

CNTA

GOYAL ARJUN serves as Director at Centessa Pharmaceuticals plc (CNTA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$20.87M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$20.87M

Companies Traded

CNTA

Active Period

Jun 2021 – May 2025

2 total trades

Most Recent

Buy CNTA

May 15, 2025 · $5.87M

GOYAL ARJUN's Insider Trading at Centessa Pharmaceuticals plc (CNTA)

Buys

2 · $20.87M

Sells

0 · $0.00

Total Shares Bought

1,212,585

Total Shares Sold

CNTA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
May 15, 2025	Buy	462,585	$12.68	$5.87M	0
Jun 2, 2021	Buy	750,000	$20.00	$15.00M	0

Related Insiders

Mario Alberto Accardi

President, Orexin Program

CNTASell · Feb 1, 2026

Karen M. Anderson

Chief People Officer

CNTASell · Feb 1, 2026

Tia L Bush

Chief Technology & Quality Ofc

CNTASell · Feb 1, 2026

Gregory M Weinhoff

Chief Business Officer

CNTASell · Feb 1, 2026

HUSSAIN IQBAL J

General Counsel

CNTASell · Jan 30, 2026

Explore More Insider Trading Data

CNTA Insider Trading Activity

View all insider trades at Centessa Pharmaceuticals plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity